Argentina

Argentina

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.35 (0.30 - 0.40) 2019 Modelled IHME
0.35 (0.30 - 0.40) 2018 Modelled IHME
0.35 (0.30 - 0.41) 2017 Modelled IHME
0.35 (0.30 - 0.40) 2016 Modelled IHME
0.35 (0.30 - 0.41) 2015 Modelled IHME
0.35 (0.30 - 0.41) 2014 Modelled IHME
0.36 (0.30 - 0.41) 2013 Modelled IHME
0.37 (0.31 - 0.42) 2012 Modelled IHME
0.37 (0.31 - 0.43) 2011 Modelled IHME
0.38 (0.31 - 0.44) 2010 Modelled IHME
0.38 (0.32 - 0.44) 2009 Modelled IHME
0.38 (0.32 - 0.44) 2008 Modelled IHME
0.39 (0.32 - 0.45) 2007 Modelled IHME
0.39 (0.33 - 0.45) 2006 Modelled IHME
0.39 (0.33 - 0.46) 2005 Modelled IHME
0.39 (0.33 - 0.46) 2004 Modelled IHME
0.39 (0.33 - 0.46) 2003 Modelled IHME
0.39 (0.33 - 0.46) 2002 Modelled IHME
0.4 (0.33 - 0.46) 2001 Modelled IHME
0.4 (0.33 - 0.46) 2000 Modelled IHME
0.4 (0.33 - 0.47) 1999 Modelled IHME
0.4 (0.34 - 0.47) 1998 Modelled IHME
0.41 (0.34 - 0.47) 1997 Modelled IHME
0.41 (0.34 - 0.48) 1996 Modelled IHME
0.41 (0.34 - 0.49) 1995 Modelled IHME
0.41 (0.34 - 0.49) 1994 Modelled IHME
0.41 (0.34 - 0.49) 1993 Modelled IHME
0.41 (0.34 - 0.49) 1992 Modelled IHME
0.41 (0.34 - 0.49) 1991 Modelled IHME
0.41 (0.34 - 0.49) 1990 Modelled IHME
2.1 (1.40 - 2.80) 1999 Survey/reported Silveira TR et al, 1999
0.06 (0.05 - 0.09) 2015 Modelled WHO
0.2 (0.10 - 0.30) 2016 Modelled Razavi-Shearer et al, 2018
0.77 (0.77 - 0.78) 2013 Modelled Schweitzer et al, 2015
0.4 (0.30 - 0.50) 2019 Survey/reported WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.02 (0.01 - 0.03) 2019 Modelled IHME
0.02 (0.01 - 0.03) 2018 Modelled IHME
0.02 (0.01 - 0.03) 2017 Modelled IHME
0.02 (0.01 - 0.03) 2016 Modelled IHME
0.02 (0.01 - 0.03) 2015 Modelled IHME
0.02 (0.01 - 0.03) 2014 Modelled IHME
0.02 (0.01 - 0.03) 2013 Modelled IHME
0.02 (0.01 - 0.03) 2012 Modelled IHME
0.02 (0.01 - 0.03) 2011 Modelled IHME
0.02 (0.01 - 0.03) 2010 Modelled IHME
0.02 (0.01 - 0.03) 2009 Modelled IHME
0.02 (0.01 - 0.03) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.03 (0.02 - 0.04) 2006 Modelled IHME
0.03 (0.02 - 0.05) 2005 Modelled IHME
0.04 (0.02 - 0.05) 2004 Modelled IHME
0.04 (0.03 - 0.06) 2003 Modelled IHME
0.05 (0.03 - 0.07) 2002 Modelled IHME
0.06 (0.04 - 0.08) 2001 Modelled IHME
0.07 (0.05 - 0.09) 2000 Modelled IHME
0.08 (0.05 - 0.11) 1999 Modelled IHME
0.1 (0.07 - 0.14) 1998 Modelled IHME
0.12 (0.08 - 0.17) 1997 Modelled IHME
0.14 (0.09 - 0.20) 1996 Modelled IHME
0.15 (0.09 - 0.21) 1995 Modelled IHME
0.15 (0.09 - 0.21) 1994 Modelled IHME
0.15 (0.09 - 0.21) 1993 Modelled IHME
0.15 (0.09 - 0.21) 1992 Modelled IHME
0.15 (0.09 - 0.21) 1991 Modelled IHME
0.15 (0.09 - 0.21) 1990 Modelled IHME
0.01 (0.01 - 0.01) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
136,965 (111,040 - 162,521) 1990 Modelled IHME
138,831 (114,250 - 163,396) 1991 Modelled IHME
140,505 (115,897 - 164,494) 1992 Modelled IHME
142,012 (116,965 - 166,401) 1993 Modelled IHME
143,425 (118,060 - 168,118) 1994 Modelled IHME
144,750 (118,217 - 170,541) 1995 Modelled IHME
145,568 (120,005 - 169,801) 1996 Modelled IHME
145,716 (120,822 - 169,461) 1997 Modelled IHME
145,594 (121,317 - 168,710) 1998 Modelled IHME
145,587 (121,680 - 169,856) 1999 Modelled IHME
146,048 (122,095 - 170,498) 2000 Modelled IHME
146,963 (123,192 - 171,855) 2001 Modelled IHME
148,037 (124,855 - 173,092) 2002 Modelled IHME
149,223 (126,069 - 174,193) 2003 Modelled IHME
150,460 (126,851 - 176,337) 2004 Modelled IHME
151,573 (127,050 - 177,225) 2005 Modelled IHME
152,407 (127,917 - 178,133) 2006 Modelled IHME
153,043 (128,637 - 178,810) 2007 Modelled IHME
153,597 (128,614 - 178,266) 2008 Modelled IHME
154,049 (129,499 - 179,284) 2009 Modelled IHME
154,385 (129,539 - 180,031) 2010 Modelled IHME
154,275 (129,335 - 177,763) 2011 Modelled IHME
153,612 (129,556 - 175,451) 2012 Modelled IHME
152,835 (128,969 - 174,284) 2013 Modelled IHME
152,403 (128,705 - 174,125) 2014 Modelled IHME
152,728 (129,418 - 176,289) 2015 Modelled IHME
153,648 (132,026 - 177,123) 2016 Modelled IHME
154,821 (132,541 - 181,396) 2017 Modelled IHME
156,018 (134,130 - 179,407) 2018 Modelled IHME
157,094 (134,855 - 179,476) 2019 Modelled IHME
79,000 (47,000 - 117,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
480 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.24 (1.67 - 2.99) 2019 Modelled IHME
2.26 (1.69 - 3.01) 2018 Modelled IHME
2.32 (1.73 - 3.08) 2017 Modelled IHME
2.35 (1.76 - 3.10) 2016 Modelled IHME
2.3 (1.71 - 3.01) 2015 Modelled IHME
2.29 (1.71 - 3) 2014 Modelled IHME
2.34 (1.75 - 3.07) 2013 Modelled IHME
2.37 (1.76 - 3.13) 2012 Modelled IHME
2.4 (1.80 - 3.15) 2011 Modelled IHME
2.43 (1.82 - 3.19) 2010 Modelled IHME
2.54 (1.90 - 3.32) 2009 Modelled IHME
2.72 (2.05 - 3.57) 2008 Modelled IHME
2.94 (2.20 - 3.84) 2007 Modelled IHME
2.98 (2.22 - 3.85) 2006 Modelled IHME
2.97 (2.22 - 3.87) 2005 Modelled IHME
2.95 (2.19 - 3.85) 2004 Modelled IHME
3 (2.24 - 3.90) 2003 Modelled IHME
2.96 (2.20 - 3.83) 2002 Modelled IHME
2.91 (2.16 - 3.77) 2001 Modelled IHME
2.89 (2.14 - 3.73) 2000 Modelled IHME
2.97 (2.19 - 3.83) 1999 Modelled IHME
2.98 (2.19 - 3.86) 1998 Modelled IHME
2.99 (2.19 - 3.86) 1997 Modelled IHME
2.98 (2.19 - 3.87) 1996 Modelled IHME
2.95 (2.18 - 3.80) 1995 Modelled IHME
2.95 (2.18 - 3.80) 1994 Modelled IHME
3.01 (2.22 - 3.89) 1993 Modelled IHME
3.07 (2.25 - 3.99) 1992 Modelled IHME
3.05 (2.23 - 3.98) 1991 Modelled IHME
3.08 (2.25 - 4.03) 1990 Modelled IHME
0.07 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,012 (755 - 1,348) 2019 Modelled IHME
1,013 (756 - 1,345) 2018 Modelled IHME
1,027 (767 - 1,368) 2017 Modelled IHME
1,032 (773 - 1,362) 2016 Modelled IHME
999 (744 - 1,308) 2015 Modelled IHME
985 (734 - 1,291) 2014 Modelled IHME
995 (742 - 1,304) 2013 Modelled IHME
997 (741 - 1,318) 2012 Modelled IHME
998 (747 - 1,312) 2011 Modelled IHME
1,001 (748 - 1,313) 2010 Modelled IHME
1,033 (772 - 1,349) 2009 Modelled IHME
1,093 (822 - 1,433) 2008 Modelled IHME
1,169 (874 - 1,525) 2007 Modelled IHME
1,169 (873 - 1,513) 2006 Modelled IHME
1,156 (861 - 1,504) 2005 Modelled IHME
1,135 (842 - 1,478) 2004 Modelled IHME
1,140 (849 - 1,484) 2003 Modelled IHME
1,114 (829 - 1,441) 2002 Modelled IHME
1,081 (803 - 1,403) 2001 Modelled IHME
1,063 (787 - 1,373) 2000 Modelled IHME
1,081 (798 - 1,393) 1999 Modelled IHME
1,076 (790 - 1,392) 1998 Modelled IHME
1,065 (781 - 1,377) 1997 Modelled IHME
1,052 (775 - 1,368) 1996 Modelled IHME
1,032 (764 - 1,330) 1995 Modelled IHME
1,021 (755 - 1,315) 1994 Modelled IHME
1,031 (760 - 1,333) 1993 Modelled IHME
1,042 (763 - 1,352) 1992 Modelled IHME
1,022 (747 - 1,334) 1991 Modelled IHME
1,019 (744 - 1,334) 1990 Modelled IHME
1,517 2016 Modelled WHO
838 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
16 (11 - 23) 2019 Modelled IHME
16 (11 - 23) 2018 Modelled IHME
16 (11 - 23) 2017 Modelled IHME
16 (11 - 23) 2016 Modelled IHME
16 (11 - 23) 2015 Modelled IHME
16 (11 - 23) 2014 Modelled IHME
16 (11 - 23) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (12 - 24) 2011 Modelled IHME
17 (12 - 24) 2010 Modelled IHME
17 (12 - 24) 2009 Modelled IHME
17 (12 - 24) 2008 Modelled IHME
17 (12 - 25) 2007 Modelled IHME
18 (12 - 25) 2006 Modelled IHME
18 (12 - 25) 2005 Modelled IHME
18 (12 - 25) 2004 Modelled IHME
18 (12 - 25) 2003 Modelled IHME
18 (12 - 25) 2002 Modelled IHME
18 (12 - 25) 2001 Modelled IHME
18 (12 - 25) 2000 Modelled IHME
18 (12 - 25) 1999 Modelled IHME
18 (12 - 25) 1998 Modelled IHME
18 (12 - 25) 1997 Modelled IHME
17 (12 - 25) 1996 Modelled IHME
17 (12 - 25) 1995 Modelled IHME
17 (12 - 25) 1994 Modelled IHME
17 (12 - 25) 1993 Modelled IHME
17 (12 - 25) 1992 Modelled IHME
17 (12 - 25) 1991 Modelled IHME
17 (12 - 24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
82 2019 Survey/reported WHO/UNICEF
82 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
81 2016 Survey/reported WHO/UNICEF
84 2015 Survey/reported WHO/UNICEF
87 2014 Survey/reported WHO/UNICEF
85 2013 Survey/reported WHO/UNICEF
88 2012 Survey/reported WHO/UNICEF
85 2011 Survey/reported WHO/UNICEF
79 2010 Survey/reported WHO/UNICEF
81 2009 Survey/reported WHO/UNICEF
79 2008 Survey/reported WHO/UNICEF
76 2007 Survey/reported WHO/UNICEF
72 2006 Survey/reported WHO/UNICEF
71 2005 Survey/reported WHO/UNICEF
65 2004 Survey/reported WHO/UNICEF
72 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
86 2019 Survey/reported WHO/UNICEF
74 2020 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Proportion of persons living with HBV diagnosed

National
Download
Value (%) Year Type Source
60 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

Proportion of diagnosed HBV persons receiving appropriate treatment

National
Download
Value (%) Year Type Source
80 2019 Survey/reported Communications with Argentina Ministry of Health

Number of needles/syringes per PWID per year

HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Not Adopted
No patient co-pays for HBsAg testing
Partially Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Registration of originator HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Not Adopted
No patient co-pays for anti-HCV testing
Partially Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Public budget line for testing and treatment
Adopted

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.40 - 0.60) 2019 Modelled IHME
0.5 (0.41 - 0.60) 2018 Modelled IHME
0.49 (0.40 - 0.60) 2017 Modelled IHME
0.49 (0.40 - 0.60) 2016 Modelled IHME
0.48 (0.39 - 0.59) 2015 Modelled IHME
0.46 (0.38 - 0.57) 2014 Modelled IHME
0.44 (0.36 - 0.54) 2013 Modelled IHME
0.42 (0.34 - 0.51) 2012 Modelled IHME
0.39 (0.32 - 0.48) 2011 Modelled IHME
0.38 (0.30 - 0.46) 2010 Modelled IHME
0.37 (0.30 - 0.45) 2009 Modelled IHME
0.36 (0.29 - 0.43) 2008 Modelled IHME
0.35 (0.29 - 0.42) 2007 Modelled IHME
0.35 (0.29 - 0.41) 2006 Modelled IHME
0.34 (0.28 - 0.41) 2005 Modelled IHME
0.34 (0.28 - 0.40) 2004 Modelled IHME
0.33 (0.27 - 0.40) 2003 Modelled IHME
0.33 (0.27 - 0.40) 2002 Modelled IHME
0.33 (0.27 - 0.40) 2001 Modelled IHME
0.33 (0.27 - 0.40) 2000 Modelled IHME
0.33 (0.27 - 0.40) 1999 Modelled IHME
0.33 (0.27 - 0.40) 1998 Modelled IHME
0.33 (0.27 - 0.40) 1997 Modelled IHME
0.33 (0.27 - 0.40) 1996 Modelled IHME
0.34 (0.28 - 0.41) 1995 Modelled IHME
0.35 (0.28 - 0.41) 1994 Modelled IHME
0.36 (0.30 - 0.43) 1993 Modelled IHME
0.38 (0.32 - 0.46) 1992 Modelled IHME
0.41 (0.34 - 0.49) 1991 Modelled IHME
0.44 (0.36 - 0.53) 1990 Modelled IHME
0.8 (0.30 - 1.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.52 (0.23 - 0.78) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.5 (0.50 - 2.50) 2014 Survey/reported Gower et al, 2014
1.5 2019 Modelled Jin et al. 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
54.6 (51.10 - 58.10) 2001 Survey/reported Weissenbacher M et al, 2003
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
3.4 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
144,787 (118,599 - 175,341) 1990 Modelled IHME
137,013 (113,214 - 165,199) 1991 Modelled IHME
129,762 (107,260 - 155,881) 1992 Modelled IHME
123,697 (102,051 - 148,208) 1993 Modelled IHME
119,543 (98,614 - 143,144) 1994 Modelled IHME
117,983 (96,826 - 141,868) 1995 Modelled IHME
118,028 (96,993 - 142,142) 1996 Modelled IHME
118,264 (97,163 - 142,670) 1997 Modelled IHME
118,755 (97,821 - 143,290) 1998 Modelled IHME
119,547 (98,140 - 145,023) 1999 Modelled IHME
120,647 (98,782 - 146,175) 2000 Modelled IHME
122,203 (100,282 - 147,459) 2001 Modelled IHME
124,289 (102,049 - 149,763) 2002 Modelled IHME
126,810 (104,280 - 152,291) 2003 Modelled IHME
129,661 (107,002 - 155,298) 2004 Modelled IHME
132,635 (109,939 - 159,215) 2005 Modelled IHME
135,810 (112,056 - 162,582) 2006 Modelled IHME
139,519 (115,183 - 167,444) 2007 Modelled IHME
143,885 (117,880 - 173,730) 2008 Modelled IHME
148,911 (121,258 - 181,770) 2009 Modelled IHME
154,597 (125,291 - 190,547) 2010 Modelled IHME
162,972 (132,415 - 199,557) 2011 Modelled IHME
174,665 (142,617 - 213,167) 2012 Modelled IHME
187,614 (153,547 - 228,464) 2013 Modelled IHME
199,671 (162,611 - 243,214) 2014 Modelled IHME
208,513 (168,987 - 255,452) 2015 Modelled IHME
214,578 (176,145 - 261,560) 2016 Modelled IHME
218,893 (179,053 - 266,732) 2017 Modelled IHME
221,617 (181,683 - 269,175) 2018 Modelled IHME
223,803 (182,239 - 268,735) 2019 Modelled IHME
326,000 (144,000 - 490,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
58,200 (25,600 - 87,400) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

National
Download
Value Year Type Source
538 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
7.82 (6.26 - 9.59) 2019 Modelled IHME
7.79 (6.22 - 9.55) 2018 Modelled IHME
7.87 (6.27 - 9.72) 2017 Modelled IHME
7.86 (6.25 - 9.68) 2016 Modelled IHME
7.51 (6.01 - 9.26) 2015 Modelled IHME
7.31 (5.81 - 8.96) 2014 Modelled IHME
7.26 (5.82 - 8.92) 2013 Modelled IHME
7.14 (5.70 - 8.81) 2012 Modelled IHME
6.99 (5.53 - 8.68) 2011 Modelled IHME
6.83 (5.36 - 8.47) 2010 Modelled IHME
6.68 (5.28 - 8.25) 2009 Modelled IHME
6.56 (5.19 - 8.13) 2008 Modelled IHME
6.54 (5.18 - 8.07) 2007 Modelled IHME
6.21 (4.94 - 7.67) 2006 Modelled IHME
6.06 (4.80 - 7.51) 2005 Modelled IHME
6.04 (4.81 - 7.46) 2004 Modelled IHME
6.17 (4.92 - 7.63) 2003 Modelled IHME
6.13 (4.90 - 7.63) 2002 Modelled IHME
6.05 (4.83 - 7.50) 2001 Modelled IHME
6.01 (4.79 - 7.50) 2000 Modelled IHME
6.16 (4.89 - 7.67) 1999 Modelled IHME
6.18 (4.88 - 7.70) 1998 Modelled IHME
6.15 (4.82 - 7.70) 1997 Modelled IHME
6.1 (4.77 - 7.62) 1996 Modelled IHME
6.03 (4.72 - 7.55) 1995 Modelled IHME
6.03 (4.70 - 7.55) 1994 Modelled IHME
6.18 (4.85 - 7.76) 1993 Modelled IHME
6.35 (4.97 - 7.94) 1992 Modelled IHME
6.36 (4.94 - 7.94) 1991 Modelled IHME
6.5 (5.04 - 8.16) 1990 Modelled IHME
0.22 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,527 (2,823 - 4,327) 2019 Modelled IHME
3,484 (2,783 - 4,275) 2018 Modelled IHME
3,489 (2,780 - 4,313) 2017 Modelled IHME
3,451 (2,745 - 4,253) 2016 Modelled IHME
3,266 (2,612 - 4,024) 2015 Modelled IHME
3,142 (2,500 - 3,851) 2014 Modelled IHME
3,089 (2,473 - 3,792) 2013 Modelled IHME
3,005 (2,399 - 3,704) 2012 Modelled IHME
2,907 (2,300 - 3,609) 2011 Modelled IHME
2,808 (2,204 - 3,483) 2010 Modelled IHME
2,716 (2,147 - 3,355) 2009 Modelled IHME
2,637 (2,084 - 3,266) 2008 Modelled IHME
2,597 (2,059 - 3,205) 2007 Modelled IHME
2,440 (1,940 - 3,016) 2006 Modelled IHME
2,356 (1,866 - 2,918) 2005 Modelled IHME
2,321 (1,847 - 2,868) 2004 Modelled IHME
2,343 (1,868 - 2,898) 2003 Modelled IHME
2,305 (1,840 - 2,869) 2002 Modelled IHME
2,248 (1,796 - 2,790) 2001 Modelled IHME
2,213 (1,761 - 2,760) 2000 Modelled IHME
2,245 (1,783 - 2,795) 1999 Modelled IHME
2,228 (1,758 - 2,775) 1998 Modelled IHME
2,195 (1,721 - 2,747) 1997 Modelled IHME
2,154 (1,687 - 2,694) 1996 Modelled IHME
2,108 (1,652 - 2,641) 1995 Modelled IHME
2,088 (1,628 - 2,614) 1994 Modelled IHME
2,120 (1,663 - 2,661) 1993 Modelled IHME
2,155 (1,685 - 2,694) 1992 Modelled IHME
2,133 (1,655 - 2,661) 1991 Modelled IHME
2,152 (1,670 - 2,701) 1990 Modelled IHME
1,599 2016 Modelled WHO
3,730 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
36 (27 - 46) 2019 Modelled IHME
36 (27 - 46) 2018 Modelled IHME
36 (27 - 46) 2017 Modelled IHME
36 (27 - 46) 2016 Modelled IHME
36 (27 - 46) 2015 Modelled IHME
36 (27 - 45) 2014 Modelled IHME
36 (27 - 45) 2013 Modelled IHME
36 (27 - 46) 2012 Modelled IHME
36 (27 - 46) 2011 Modelled IHME
36 (27 - 46) 2010 Modelled IHME
36 (27 - 46) 2009 Modelled IHME
36 (27 - 46) 2008 Modelled IHME
36 (27 - 46) 2007 Modelled IHME
36 (27 - 46) 2006 Modelled IHME
36 (26 - 46) 2005 Modelled IHME
36 (27 - 46) 2004 Modelled IHME
36 (27 - 45) 2003 Modelled IHME
36 (26 - 45) 2002 Modelled IHME
36 (26 - 45) 2001 Modelled IHME
36 (26 - 45) 2000 Modelled IHME
35 (26 - 45) 1999 Modelled IHME
35 (26 - 44) 1998 Modelled IHME
35 (26 - 44) 1997 Modelled IHME
35 (25 - 44) 1996 Modelled IHME
34 (25 - 44) 1995 Modelled IHME
34 (25 - 43) 1994 Modelled IHME
34 (25 - 43) 1993 Modelled IHME
34 (25 - 43) 1992 Modelled IHME
34 (25 - 44) 1991 Modelled IHME
34 (25 - 44) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of tests for HCV administered

National
Download
Value Year Year Type Source
276,480 2019 Survey/reported Communications with Argentina Ministry of Health
207,450 2018 Survey/reported Communications with Argentina Ministry of Health
Showing out of
Show more

Number of persons treated for HCV

National
Download
Value Year Type Source
1,200 2016 Survey/reported WHO, 2018
1,971 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina.
2,241 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
50 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

Proportion of persons diagnosed who were cured with new DAAs

National
Download
Value (%) Year Type Source
4.5 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2000
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Not Adopted
No patient co-pays for HBsAg testing
Partially Adopted
Simplified care: No treatment co-pays
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Partially Adopted
Registration of originator HCV DAAs
Adopted
Licensed point-of-care PCR testing to detect HCV
Not Adopted
No patient co-pays for anti-HCV testing
Partially Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Public budget line for testing and treatment
Adopted

Overview

Resources